Moreover, the previously mentioned nested case-control study of data from the UK general practice database showed that β blockers, angiotensin converting enzyme inhibitors and non-losartan angiotensin II receptor blockers increased the risk of gout (Choi et al., 2012). Here, ACE is linked to gout.